Cancer Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
How Pfizer Is Rethinking What’s Possible in Cancer Care
For people living with cancer and those who love them, every moment matters. Cancer remains one of the greatest healthcare challenges of our lifetime, and Pfizer is working with urgency to transform scientific advances into potential life-changing medicines.In a sponsored interview, Jeff Legos, Pfizer’s Chief Oncology Officer, sat down with Jessica Sibley, CEO of TIME, to discuss why this mission is personal for him, the responsibility he feels as Pfizer works toward its ambition of delivering...
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission
In 2013, Josh Raub’s life was going according to plan. At 29 years old, he was working at his dream job as a professor and pharmacy specialist at an academic medical center in Detroit. He and his wife had just bought their first home and were talking about starting a family. “It was just this perfect future that we were planning for ourselves,” he says.Then he got sick. It didn’t seem like much at first: a low-grade fever, night sweats, fatigue. He thought it might be the flu. He’d get better...
September Social Media Round-Up—Prostate Cancer Awareness, TIME Executives of the Year, and More
As we enter fall, the days are getting shorter and the nights are getting cooler, but Pfizer’s social media channels are as active as ever.In September, we highlighted Blood and Prostate Cancer Awareness months, shared insights into how Pfizer’s helping combat counterfeit medicines, and released new episodes of “What’s In My Lab.” Meanwhile CEO Albert Bourla met with breast cancer patients and health care workers in Kenya and paid tribute to those we lost on the 25th anniversary of 9/11. Our...
Bourla at Concordia: The Business of Better Health
Each September, government officials, global executives, NGOs and other key leaders converge on New York for the United Nations General Assembly. The week is marked by direct, cross-sector dialogues about the state of the world and how we can plan for a prosperous future.At the 2026 Concordia Annual Summit, Albert Bourla joined that conversation via a mainstage discussion with Alice Park, senior health correspondent at TIME, titled "The Business of Better Health."As the global population ages...
Behind the Science: Reprogramming Resistance to Prostate Cancer Treatment
Prostate cancer is one of the most common – and most lethal – cancers in men.1 In the United States alone, nearly 300,000 new cases are diagnosed each year, and it remains the second-leading cause of cancer death among men.2Prostate cancer, in its early stages, is driven by androgens — male hormones such as testosterone – and treatment has the potential to be effective when caught early. Block the androgens, and you can block the fuel the cancer needs to grow.But cancer is adaptive and works to...
Decoding Tumors: Inside the Spatial Revolution in Cancer Research
Cancer emerges from the very same cellular machinery that keeps us alive. It puzzles both pathologists and the immune system because tumors, unlike infections, share the basic structures and behavioral blueprints of healthy, normal tissue, a resemblance that can let them slip past immune surveillance undetected. For more than a century, cancer was described by pathologists as a “caricature” of healthy tissue, bizarre distortions of otherwise normal cells.1 But tumors act almost like organisms...
8 Lessons I’ve Learned as a Cancer Survivor
For most of my life I’ve lived by the belief that everything happens for a reason. The challenge is that I don’t always know what that reason is. That was certainly the case three years ago, when I was diagnosed with Leiomyosarcoma.It took a long time for me to learn what was making me sick. After searching for answers, an MRI revealed a large tumor deep in my abdomen. Following surgery to remove it, I learned that I had a rare and aggressive cancer that grows in the body’s soft tissues. Still...
June Social Media Round-Up—2025 Impact Report, ADA 2026, and More
School is out for the summer, but Pfizer colleagues are still hard at work. In June, we released our 2025 Impact Report, shared risks of fake medicines on World Anti-Counterfeit Day, and raised awareness of menstrual-related migraine and more.Pfizer has also been present at many conferences this past month—from ASCO and ADA to EHA and AHS 2026, and our leadership team has been highlighting the latest data that we’ve shared at these events. Meanwhile, CEO Albert Bourla joined the CNBC CEO Council...
A Prostate Cancer Survivor Shares the Importance of Early Detection—and Why Knowing Your History, Monitoring PSA and Talking to Your Doctor Matters
For years, senior oncology account specialist Dan Morgan has helped doctors understand what Pfizer medications can do for cancer patients. In 2024, the script flipped when he became a patient himself. Thanks to his work, Dan knew just how to advocate for his health by requesting blood tests and diagnostic exams, and his prostate cancer was detected early, before he even felt sick.Dan chose to work in oncology because of his family history. Back when he was in college, his dad had prostate cancer...
Living Longer with Cancer: Redefining What It Means to Survive
The sixth season of Science Will Win, Pfizer's award-winning podcast, focused on cancer. The six episodes explored the disease from every angle, from its rising incidence in younger populations to the precision medicine tools helping clinicians catch it earlier and treat it more effectively. Host Dr. Raven Baxter delved deep into each topic, interviewing doctors, scientists, researchers, and Pfizer colleagues to glean their insights and discuss the ongoing effort to conquer cancer.To further...
Multiple Myeloma: Shedding Light on a Rare but Complex Blood Cancer
Donna is more than a cancer patient: Donna is a wife, mother, grandmother, sister, and friend who has a full life outside of treatment. Her journey with multiple myeloma has revealed depths of resilience and strength that have long served her in all of those roles.“We have multiple myeloma…but that should not define us,” Donna shared in a recent video interview.It’s a message that Max Merz MD, MHBA, hematologist/oncologist and associate attending physician at Memorial Sloan Kettering Cancer...
May Social Media Round-Up—ASCO, Q1 2026 Results, and More
Summer’s approaching fast, but here at Pfizer the work doesn’t stop. So before you get outside to enjoy the warmer weather, catch up with the latest activity on our social channels.May has been chock full of highlights—from sharing the latest data across our cancer work at ASCO 2026 to a feature in TIME highlighting how we bring science from the lab to life, we’re offering looks behind the science of Pfizer’s research. Next, review Pfizer’s first quarter results, courtesy of CEO Albert Bourla...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.